Rafael Holdings, Inc. (RFL)

Real Estate Real Estate Services

2.20 $

Closing price · As of: 20. Jul 2026

Add to watchlist

Appears in These Scanners

This stock currently matches 12 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

U/D Accumulation

Breakout & Setup

Inside Day at Highs

Momentum & Trend

21-EMA Trend Above the 50- & 200-SMA Gary Antonacci: Dual Momentum (Stock Adaptation) High ADR (≥5%) RS Leader (≥90) Stan Weinstein: Checklist Stan Weinstein: Stage 2

Risk & Weakness

Going Concern (Distress Proxy) Insolvency Radar: Cash Running Low Mike Webster: Overextended (Webby RSI)

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap

0.1Mrd. $

Shares Outstanding

51Mio.

Float

62.2%

Beta

0.3

Performance

Perf. 1M

127.30%

Perf. 3M

152.80%

Perf. 6M

167.80%

YTD Performance (%)

126.30%

52-Week-High Distance

-8.1%

Valuation

P/E

–

Forward P/E

0.0

PEG

–

P/B

1.9

P/S

157.8

EV/EBITDA

5.4

Price/FCF

–

Profitability

Gross Margin

95.1%

EBIT Margin

–

Net Margin

0.0%

Return on Equity

-37.6%

Return on Assets

-22.8%

Balance Sheet & Safety

Equity Ratio

–

Debt/Equity

0.01

Altman Z

0.79

weak

Piotroski

2 von 9

Growth

Sales Growth Last Quarter

-50.60%

EPS Growth Last Quarter

0.00%

Sales Growth (Year)

43.96%

Forward Sales Growth

–

Forward EPS Growth

–

Quality & Screener

Stage

Top 10%

RS Rating

EPS Rating

weak

Piotroski

2 von 9

Fundamental Rating

D (-36 von 100)

Altman Z

0.79

AI Rating

Neutral

Geprüft am 13.07.2026 gegen die beiden Geschäftsberichte (10-K) für die Geschäftsjahre 2025 (eingereicht 29.10.2025) und 2024 (07.11.2024) sowie die vier jüngsten Quartalsberichte (10-Q) bis zum 30.04.2026: In sämtlichen ausgewerteten SEC-Filings von Rafael Holdings findet sich kein einziger belastbarer KI-Bezug — weder „artificial intelligence“ noch „machine learning“, „generative“ oder „large language model“ tauchen im Geschäftsmodell, in der Segmentberichterstattung oder in den Risk Factors auf. Rafael Holdings ist eine Biotech-Beteiligungs-Holding: Kerngeschäft ist die Entwicklung des Wirkstoffs Trappsol® Cyclo™ gegen die seltene Kinderkrankheit Niemann-Pick Typ C1 (über die 2025 übernommene Cyclo Therapeutics) sowie Minderheits- und Mehrheitsbeteiligungen an weiteren Pharma- und Medizingeräte-Firmen; dazu kommt eine einzige Rest-Immobilie in Jerusalem. KI ist weder Umsatzquelle noch dokumentierter operativer Hebel noch ein im 10-K konkret benanntes Geschäftsrisiko fürs eigene Modell. Nach dem Kriterienkatalog (Vorrang verkauft > bedroht > nutzt > neutral) bleibt es damit klar bei „neutral“ — dokumentierter Negativ-Befund, keine belastbaren Treffer in den geprüften Filings.

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-K 2025-10-29 · 10-K 2024-11-07 · 10-Q 2026-06-11 · 10-Q 2026-03-16 · 10-Q 2025-12-12 · 10-Q 2025-06-11

Rated on July 13, 2026 · How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Sales Per Quarter ($M)

Earnings Per Share Per Quarter ($)

Net Margin Per Quarter (%)

Operating Cash Flow Per Quarter ($M)

Free Cash Flow Per Quarter ($M)

Sales Growth vs. Year-Ago Quarter (%)

EPS Growth vs. Year-Ago Quarter (%)

Price Change in Quarter (%)

Quarterly Figures

Quarterly Figures
Quarter	EPS (Earnings Per Share)	EPS YoY (%)	Sales YoY (%)	Net Margin (%)	OCF ($M)	FCF ($M)
2025: Q1	-0.09	-176.70	13.20	-6,027.30	-2	-2
2025: Q2	-0.09	–	7.70	-1,320.20	-3	-3
2025: Q3	-0.24	–	112.10	-3,455.40	-10	-10
2025: Q4	-0.19	–	87.50	-4,090.00	-7	-7
2026: Q1	-0.13	–	174.00	-3,041.20	-8	-8
2026: Q2	-0.08	–	-50.60	-2,360.90	-7	-7

What Do These Terms Mean?

EPS (Earnings Per Share):: Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):: Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:: All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:: What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):: The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):: Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Rafael Holdings, Inc. hält in erster Linie Beteiligungen an Pharmaunternehmen in der klinischen und Frühphase sowie an Medizinprodukten in den USA und Israel.

Employees	21
Headquarters	Newark, NJ
Website	rafaelholdings.com
IPO Date	26. Mar 2018

Management

Management
Name	Title	Birth Year
Howard S. Jonas	CEO, President, Founder & Executive Chairman	1956
David A. Polinsky Esq.	Chief Financial Officer	1972
Joshua M. Fine	Chief Operating Officer	1982
Joyce J. Mason Esq.	Corporate Secretary	1959

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.